Stocks Comparison
Avantor vs Bio-Rad Laboratories: revenue, profit, margins and growth compared
Avantor brought in $6.6B of revenue in fiscal 2025, Bio-Rad Laboratories $2.6B in fiscal 2025. Revenue changed by -3.4% at Avantor and +0.7% at Bio-Rad Laboratories on the year before, so Bio-Rad Laboratories grew faster. Avantor kept -8.1% of its revenue as net profit, Bio-Rad Laboratories 29.4%. Free cash flow was $495M at Avantor and $374.6M at Bio-Rad Laboratories.
Side by side, latest fiscal year
| AVTR | BIO | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $6.6B | $2.6B |
| Revenue growth | -3.4% | +0.7% |
| Net income | -$530.2M | $759.9M |
| Net margin | -8.1% | 29.4% |
| Free cash flow | $495M | $374.6M |
| Free cash flow margin | 7.6% | 14.5% |
| Earnings per share (diluted) | -$0.78 | $27.85 |
| Cash | $365.4M | $529.8M |
| Debt | $3.9B | $1.2B |
| Price to earnings | n/a | 13.7 |
| Market value | $10.3B | $10.2B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #101 of 451 · Industrials | #194 of 451 · Industrials |
Over the years
Questions about Avantor and Bio-Rad Laboratories
Which is bigger by revenue, Avantor or Bio-Rad Laboratories?
Avantor is bigger by revenue: $6.6B in fiscal 2025, against $2.6B for Bio-Rad Laboratories in fiscal 2025.
Which keeps more of its revenue as profit, Avantor or Bio-Rad Laboratories?
Avantor had a net margin of -8.1% in fiscal 2025; Bio-Rad Laboratories had 29.4% in fiscal 2025.
Which grew revenue faster, Avantor or Bio-Rad Laboratories?
In their latest fiscal years revenue changed by -3.4% at Avantor and +0.7% at Bio-Rad Laboratories.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.